Transurethral bladder tumor resection alters fibronectin expression in transitional carcinoma cell lines

J Urol. 1997 Mar;157(3):1136-43.

Abstract

Purpose: To examine the effect of TGF beta 1 and post-transurethral resection of bladder tumor (TURBT) urine on fibronectin (FN) expression by transitional carcinoma (TCC) cell lines.

Materials and methods: Northern analysis and rtPCR for mRNA transcripts, in combination with ELISA and immunohistochemistry for protein, were used to quantify the effect of TGF beta 1 and post-TURBT urine on cellular expression of FN in two TCC lines, 253J and 647V. The TGF beta 1-dependent nature of the response seen in post-TURBT urine was confirmed using exogenous TGF beta 1 or blocking antibodies to TGF beta 1. Active and latent levels of TGFb1 were measured in post-TURBT urine and urine "spiked" cell culture media.

Results: Baseline FN expression was low in the poorly differentiated, metastatic 253J line and high in the moderately differentiated 647V line. TGF beta 1 and post-TURBT urine increased FN expression at both the mRNA and protein levels in the 253J line. Anti-TGF beta 1 antibodies inhibited the effect of post-TURBT urine on FN expression in 253J cells. High levels of TGF beta 1 decreased FN expression in 647V cells. Only latent TGF beta 1 was present in samples of urine and media.

Conclusions: FN production in low expressing TCC lines can be augmented by exogenous TGF beta 1. TURBT increases latent urinary TGF beta 1 which in turn affects TCC FN expression. Altered tumor expression of FN following TURBT may influence the effectiveness of intravesical BCG.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Carcinoma, Transitional Cell / metabolism*
  • Carcinoma, Transitional Cell / surgery*
  • Fibronectins / biosynthesis*
  • Fibronectins / genetics
  • Humans
  • Postoperative Period
  • RNA, Messenger / analysis
  • Transforming Growth Factor beta
  • Tumor Cells, Cultured
  • Urethra
  • Urinary Bladder Neoplasms / metabolism*
  • Urinary Bladder Neoplasms / surgery*

Substances

  • Fibronectins
  • RNA, Messenger
  • Transforming Growth Factor beta